January 29, 2015 1:50 PM ET

Company Overview of The University of Massachusetts Medical School

Company Overview

55 Lake Avenue North

Worcester, MA 01655

United States



Key Executives for The University of Massachusetts Medical School

Director for Diabetes Center of Excellence and Division Chief of Diabetes
Director for the Cancer Center of Excellence
Senior Director of Human Stem Cell Bank & Registry
Compensation as of Fiscal Year 2014.

The University of Massachusetts Medical School Key Developments

Voyager Therapeutics and The University of Massachusetts Medical School Announce Strategic Collaboration for Viral Vector Manufacturing

Voyager Therapeutics announced entered into a strategic collaboration with MassBiologics of the University of Massachusetts Medical School (UMMS). Through the collaboration, MassBiologics and Voyager Therapeutics will establish scalable processes for manufacturing recombinant adeno-associated viral (rAAV) vector products using current good manufacturing practices (cGMP). The collaboration will combine Voyager’s rAAV production technology platform with the manufacturing expertise and infrastructure of MassBiologics. Scientists from Voyager and MassBiologics will work together to establish Voyager’s proprietary third generation baculovirus/Sf9 process for the production of rAAV vectors.

The University of Massachusetts Medical School Wins $2.56 Million Federal Contract

The University of Massachusetts Medical School won a $2,556,933 federal contract from the U.S. Department of Health and Human Services' National Institutes of Health, Bethesda, Maryland, for large scale T cell epitope discovery.

UMass Medical School Receives Multi-Million Dollar Contract to Manage Health Care at Federal Correctional Institution in New York

The Federal Bureau of Prisons has awarded the University of Massachusetts (UMass) Medical School a multimillion dollar contract to manage comprehensive medical services for nearly 1,000 inmates at the Federal Correctional Institution (FCI) located in Ray Brook, New York. The five-year agreement is valued at a total of $8 million, and becomes UMass Medical School's fourth federal correctional health contract. The Health and Criminal Justice Program, part of UMass Medical School's Commonwealth Medicine division, will manage the contract. The medical school's work at FCI Ray Brook will in the month June. The contract calls for UMass Medical School to coordinate inpatient and outpatient care provided by specialist physicians at the correctional facility and in community settings. The medical school will manage scheduling and handle all claims associated with the care.

Similar Private Companies By Industry

Company Name Region
Vertex Research United States
AirTran Airways, Inc. United States
Arundel Engineering Corporation United States
Wilderidge Apartments, LLC United States
Pleasant Oaks Landfill TX, LP United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact The University of Massachusetts Medical School, please visit www.umassmed.edu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.